DUBLIN, Feb. 13, 2017 /PRNewswire/ -- Endo
International plc (NASDAQ / TSX: ENDP) will announce its
fourth-quarter and full-year 2016 financial results and provide an
update on its ongoing corporate strategic review on February 28, 2017. Members of its senior
management team will host a conference call and webcast before the
U.S. financial markets open at 8:30 a.m.
ET.
The dial-in number to access the call is U.S./Canada (866) 497-0462, International (678)
509-7598, and the passcode is 58581981. Please dial in 10 minutes
prior to the scheduled start
time.
A replay of the call will be available from February 28, 2017 at 11:30
a.m. ET until 12:30 p.m. ET on March
14, 2017 by dialing U.S./Canada (855) 859-2056, International (404)
537-3406, and entering the passcode
58581981.
A simultaneous webcast of the call can be accessed by visiting
www.endo.com. In addition, a replay of the webcast will be
available until 12:30 p.m. ET on
March 14, 2017. The replay can be
accessed by clicking the Investor Relations section of the
website.
About Endo International plc
Endo International plc
(NASDAQ / TSX: ENDP) is a global specialty pharmaceutical company
focused on improving patients' lives while creating shareholder
value. Endo develops, manufactures, markets and distributes quality
branded and generic pharmaceutical products as well as
over-the-counter medications through its operating companies. Endo
has global headquarters in Dublin,
Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.